Helen Luo

Sep 30, 2024 | bioprocessonline.com | Matthew Pillar |Jonathan Carson |Helen Luo

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly regarding using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. On Business of Biotech, the Chief Business Officer at ProFluent Bio shares her story and makes a pragmatic case for the transformative value of AI to biotech builders.